Syntezza Bioscience

Company Overview

Snapshot

Founded in January 2004, Syntezza Bioscience operates with 11–50 employees, providing molecular biology products and services. The company is a key player in the Health Tech & Life Sciences sector, focusing on the development and distribution of specialized biological products.

Business overview

Syntezza Bioscience specializes in providing and distributing molecular biology products and services. Its offerings include custom DNA and RNA oligos, genes, enzymes, peptides, research kits, and reagents, specifically designed for Next-Generation Sequencing (NGS) and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) screens. The company also delivers Sanger and NGS sequencing services and undertakes contract research projects within the diagnostics field, serving the pharmaceuticals and life sciences industries.

Company Intelligence Q&A

What is Syntezza Bioscience's primary focus?

Syntezza Bioscience primarily focuses on providing and distributing molecular biology products and services, including custom DNA and RNA oligos, genes, enzymes, peptides, research kits, and reagents.

Which specific technologies do Syntezza Bioscience's products support?

Syntezza Bioscience's products are designated for Next-Generation Sequencing (NGS) and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) screens.

Does Syntezza Bioscience offer sequencing services?

Yes, Syntezza Bioscience offers both Sanger and NGS sequencing services.

In which field does Syntezza Bioscience conduct contract research projects?

Syntezza Bioscience leads contract research projects specifically in the diagnostics field.

What is one of the key products offered by Syntezza Bioscience?

One of the key products offered by Syntezza Bioscience is shERWOOD-UltramiR shRNA.